Friday, January 18, 2019 3:42:55 PM
To accommodate the considerable interest from the industry and the media, the Danish Medicines Agency has decided to publish the names of the companies having applied for authorisation to cultivate and handle cannabis with the intention of developing cannabis for medicinal use.
The following companies have (as at 2. January 2019) applied for permission to cultivate and handle cannabis with the intention of developing cannabis for medicinal use:
Applicants whose applications are pending a decision:
Canna Therapeutic ApS
Moffes.com ApS
Cannabis-International ApS
Scientific Leaf I/S
Cronus ApS
Steffen Knudsen
Mother Room IVS
Teknologisk Institut
MM Danish Cannabis
Applicants who have been granted authorisations:
Knud Jepsen A/S
Pharmacan IVS
Vibegårds Gartneri A/S
DANCANN (authorisation sent 20 June 2018)
Medibo Relief (authorisation sent 25 May 2018)
Drizzle Grow IVS (authorisation sent 23 May 2018)
Schroll Medical ApS (authorisation sent 12 April 2018)
Gartneriet Gårslev A/S (authorisation sent 23 March 2018)
Nordic Cannabis ApS (authorisation sent 23 March 2018)
Copenhagen Cannabis IVS (authorisation sent 23 March 2018)
Æssense Europe ApS (authorisation sent 12 January 2018)
Gistrup Green Grow (authorisation sent 15 December 2017)
Cannabis Pharm, earlier MM Bureau v/Morten Nøhr Mortensen (authorisation sent 15 December 2017)
Cantiva ApS (authorisation sent 15 December 2017)
Aurora Nordic Cannabis A/S, earlier Scandinavian Cannabis A/S (authorisation sent 15 December 2017)
Organic Cannabis Care (authorisation sent 15 December 2017)
D.W. IVS (authorisation sent 15 December 2017)
Spectrum Cannabis Denmark ApS (authorisation sent 15 December 2017)
Hemp Valley ApS (authorisation sent 15 December 2017)
MEDICAN ApS (authorisation sent 15 December 2017)
StenoCare A/S, earlier StenoCare IVS (authorisation sent 15 December 2017)
Applicants whose applications have been refused or have expired:
Danaca ApS (refusal sent 14 December 2018)
Medical Cannabis Denmark (authorisation sent 15 December 2017, the application is expired 21 December 2018)
THANSEN (refusal sent 13 november 2018)
MM Danish Cannabis (refusal sent 26 October 2018)
CanFarm ApS (refusal sent 11 October 2018)
Baylinq (refusal sent 21 December 2017)
Yoldas Akkaya (refusal sent 1 December 2017)
Applicants whose applications have been withdrawn
Poulsen Roser A/S
CanFarm ApS
https://laegemiddelstyrelsen.dk/en/special/medicinal-cannabis/companies/development-scheme/applicants-having-applied-for-permission-to-cultivate-and-handle-cannabis/
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM